Cathepsin E substrate e 是组织蛋白酶 E 的底物。Cathepsin E substrate e 的设计方式是，由于 Mca 供体和 Dnp 受体非常接近，因此在完整状态下可实现近乎完全的分子内猝灭效应。肽底物的疏水基序被蛋白酶切割后，Mca 和 Dnp 会进一步分离，从而产生明亮的荧光。
Antibacterial Library contains about 32,000 compounds, and is designed for discovery of novel antibacterials. The new antibacterial library uses substructure and shape-based searches to select molecules with privileged cores, motifs, and natural product-like scaffolds that are known to be critical for antibacterial activity.
MCE 3D 多样片段库由 5,400 个非平面片段分子组成（平均 Fsp3 值为 0.58），超过4,700个片段至少包含一个手性中心。本库设计的关键元素是 3D 结构、多样性、生物反应性等。另，库中化合物在保证高sp3中心和 3D 结构优势的同时，还有效提高了片段潜在生物活性，为基于片段的药物发现提供了更高的片段命中优化概率，增加了找到创新命中的可能性。
2024年5月，Nature杂志在线发表了题为“Dimerization and antidepressant recognition at noradrenaline transporter”的研究论文，该研究成果由中国科学院上海药物研究所完成。该研究破解了重要神经系统疾病靶标——去甲肾上腺素转运体（NET），获得了人源NET同源二聚体分别与转运天然底物去甲肾上腺素NE，以及六种选择性抗抑郁药物的结合模式，为理解NET等单胺类转运体的生理调控机制奠定了重要的理论基础。
Natural products are an attractive source with varied structures that exhibit potent biological activities, and desirable pharmacological profiles. The core scaffold of a natural product can also provide a biologically validated framework upon which to display diverse functional groups. Inspired by bioactive natural products, natural product-like compounds, occupying the same chemical space, are ideally suited to explore and to facilitate understanding of biological pathways.
MCE 10K Natural Product-like Compound Library consists of 10,000 natural product-like compounds. Each compound has scaffold of natural products or Tanimoto coefficient >0.6 with natural products. The natural-likeness scoring of these compounds is >-2. What’s more, compounds in the library are drug-like and readily available for re-supply, making it a powerful tool for new drug research and development. It can be widely applied in high-throughput screening (HTS) and high-content screening (HCS).
Cathepsin E substrate e 是组织蛋白酶 E 的底物。Cathepsin E substrate e 的设计方式是，由于 Mca 供体和 Dnp 受体非常接近，因此在完整状态下可实现近乎完全的分子内猝灭效应。肽底物的疏水基序被蛋白酶切割后，Mca 和 Dnp 会进一步分离，从而产生明亮的荧光。
RING finger protein 88; RNF88; TRIM5; TRIM5_HUMAN; TRIM5alpha; Tripartite motif containing 5; tripartite motif protein TRIM5; Tripartite motif-containing protein 5
TARC 蛋白/CC 趋化因子配体 17 蛋白
TARC/CCL17 Protein, Human 是第一个发现的与 T 细胞具有高亲和力相互作用的 CC 趋化因子，可以与 CCR4 受体结合，介导炎症，癌症以及自身免疫相关疾病的发生。TARC/CCL17 Protein, Human 是一种由 E. coli 表达的重组人TARC/CCL17(A24-S94) 蛋白。
TECK 蛋白/CC 趋化因子配体 25 蛋白
TECK/CCL25 Protein, Human 是一种 CC 趋化因子，可以与趋化因子受体 CCR9 结合作用，参与 T 细胞的发育和细胞迁移小肠的过程，以及多种炎症性疾病并促进炎症反应。对胸腺细胞、巨噬细胞和树突细胞具有趋化作用。TECK/CCL25 Protein, Human 是一种由 E. coli 表达的重组人 TECK/CCL25 蛋白。
Exodus-2 蛋白/CC 趋化因子配体 21 蛋白
Exodus-2/CCL21 Protein, Human 是一种稳态淋巴样趋化因子，有助于 T 细胞和树突状细胞进入淋巴样 T 区。可通过趋化因子受体 CCR7 和 CXCR3 发挥作用，促进纤维化和炎症细胞因子的产生。Exodus-2/CCL21 Protein, Human 是一种由 E. coli 表达的重组人 Exodus-2/CCL21(S24-P134)。
I-309 蛋白/CC 趋化因子配体 1 蛋白
I-309/CCL1 Protein, Human (CHO) 是一种细胞趋化因子，通过与细胞表面的CCR8 趋化因子受体相互作用，吸引单核细胞、自然杀伤细胞、未成熟的 B 细胞核树突状细胞，介导炎症免疫反应、病毒感染以及肿瘤发生等。I-309/CCL1 Protein, Human (CHO) 是一种由 CHO 表达的重组人CCL1(K24-K96)。
CCL22（CC 基序趋化因子配体 22）在引导激活/效应 T 淋巴细胞到达炎症部位方面发挥着关键作用，并影响 T 淋巴细胞生理学的各个方面。它对单核细胞、树突状细胞和自然杀伤细胞具有趋化活性，可作为初级活化 T 淋巴细胞的温和趋化剂，并可作为慢性活化对应物的有效趋化剂。MDC/CCL22 Protein, Human (HEK293, Fc) 是重组的 MDC/CCL22 蛋白，由 HEK293 表达，带有 C-hFc 标签。
MCP-4 蛋白/CC 趋化因子配体 13 蛋白
MCP-4/CCL13 Protein, Human 是 CC 家族趋化因子，对嗜碱性粒细胞，单核细胞，巨噬细胞，未成熟树突细胞和 T 细胞具有化学引诱作用。CCL13 可以与 CCR1、CCR2、CCR3、CCR5、CCR11 趋化因子受体结合并且能够通过其对调节肌肉、上皮和内皮细胞的作用诱导关键的免疫调节反应。MCP-4/CCL13 Protein, Human 是一种由 E. coli 表达的重组人 MCP-4/CCL13(Q24-T98) 蛋白。
MIP-5 蛋白/CC 趋化因子配体 15 蛋白
MIP-5/CCL15 Protein, Human 是一种 CC 趋化因子，对髓细胞如树突状细胞、单核细胞、中性粒细胞和一些 T 淋巴细胞具有很强的趋化性。MIP-5/CCL15 Protein, Human 可以与趋化因子受体 CCR1、CCR3 结合，在白细胞招募和炎症性疾病的发展中起着关键作用。MIP-5/CCL15 Protein, Human 是一种由 E. coli 表达的重组人 MIP-5/CCL15(Q22-I113)。
CC 趋化因子配体 4 蛋白
CCL4 Protein, Human (P.pastoris, His) 是一种 CC 趋化因子亚家族的小细胞因子，可以与细胞表面的 CCR5 趋化因子受体结合作用。能够在各种炎症条件下促进白细胞聚集，又有助于对人类免疫缺陷 1 型病毒产生免疫保护。CCL4 Protein, Human (P.pastoris, His) 是由 P. pastoris 表达的重组人 CCL4 (A24-Q92)，C 端带有 His 标签。
MPIF-1 蛋白/CC 趋化因子配体 23 蛋白
MPIF-1/CCL23 蛋白, Human (His)， 一种 CC 趋化因子，对静息 T 细胞和单核细胞具有高度趋化性，通过与趋化因子受体 CCR1 结合，介导炎症、免疫反应，可以抑制髓系祖细胞形成以及具有一定的促癌作用。MPIF-1/CCL23 蛋白, Human (His) 是一种由 E. coli 表达的重组人 MPIF-1/CCL23 (R22-N120) 蛋白，N 端带有 his 标签。
BCA-1/CXCL13 蛋白选择性吸引 B 淋巴细胞，而不影响 T 淋巴细胞、单核细胞或中性粒细胞。与其他趋化因子不同，它不会诱导 B 淋巴细胞释放钙。BCA-1/CXCL13 Protein, Human (His) 是重组的 BCA-1/CXCL13 蛋白，由 E. coli 表达，带有 N-His 标签。
CC 趋化因子配体 4 蛋白
CCL4 Protein, Human 是一种 CC 趋化因子亚家族的小细胞因子，可以与细胞表面的 CCR5 趋化因子受体结合作用。能够在各种炎症条件下促进白细胞聚集，又有助于对人类免疫缺陷 1 型病毒产生免疫保护。CCL4 Protein, Human 是由 E. coli 表达的重组人 CCL4 (A24-N92)。
CC 趋化因子配体 24 蛋白/Eotaxin-2 蛋白
CCL24/Eotaxin-2 Protein, Human 是一种 CC 趋化因子，可以与趋化因子受体 CCR3 相互作用以诱导嗜酸性粒细胞的趋化性，并介导特应性疾病、寄生虫感染和全身性疾病，以及促进细胞运输并调节炎症和纤维化活动。CCL24/Eotaxin-2 Protein, Human 是一种由 E. coli 表达的重组人 CCL24/Eotaxin-2(V27-A104) 蛋白。
HCC-1 蛋白/CC趋化因子配体 14 蛋白
HCC-1/CCL14 Protein, Human (74a.a, His) 是 CC 家族趋化因子，对嗜碱性粒细胞，单核细胞，巨噬细胞，未成熟树突细胞和 T 细胞具有化学引诱作用。CCL13 可以与 CCR1、CCR2、CCR3、CCR5、CCR11 趋化因子受体结合并且能够通过其对调节肌肉、上皮和内皮细胞的作用诱导关键的免疫调节反应。HCC-1/CCL14 Protein, Human (74a.a, His) 是一种由 E. coli 表达的重组人 MCP-4/CCL13(T20-N93) 蛋白，N 端带有 his 标签。
MPIF-1 蛋白/CC 趋化因子配体 23 蛋白
MPIF-1/CCL23 蛋白, Human (P.pastoris, His)， 一种 CC 趋化因子，对静息 T 细胞和单核细胞具有高度趋化性，通过与趋化因子受体 CCR1 结合，介导炎症、免疫反应，可以抑制髓系祖细胞形成以及具有一定的促癌作用。MPIF-1/CCL23 蛋白, Human (P.pastoris, His)是一种由 P. pastoris 表达的重组人 MPIF-1/CCL23 (R46-N120) 蛋白，C 端带有 his 标签。
CC 趋化因子配体 24 蛋白/Eotaxin-2 蛋白
CCL24/Eotaxin-2 Protein, Rat 是一种 CC 趋化因子，可以与趋化因子受体 CCR3 相互作用以诱导嗜酸性粒细胞的趋化性，并介导特应性疾病、寄生虫感染和全身性疾病，以及促进细胞运输并调节炎症和纤维化活动。CCL24/Eotaxin-2 Protein, Rat 是一种由 E. coli 表达的重组大鼠 CCL24/Eotaxin-2(V27-V119) 蛋白。
MIP-5 蛋白/CC 趋化因子配体 15 蛋白
MIP-5/CCL15 Protein, Human (68a.a, His) 是一种 CC 趋化因子，对髓细胞如树突状细胞、单核细胞、中性粒细胞和一些 T 淋巴细胞具有很强的趋化性。MIP-5/CCL15 Protein, Human (68a.a, His) 可以与趋化因子受体 CCR1、CCR3 结合，在白细胞招募和炎症性疾病的发展中起着关键作用。MIP-5/CCL15 Protein, Human (68a.a, His) 是一种由 E. coli 表达的重组人 MIP-5/CCL15 (S46–I113)，在 C 端带有一个his标签。
TAFA Chemokine Like Family Member 1; FAM19A1; TAFA-1; Family With Sequence Similarity 19 Member A1, C-C motif Chemokine Like; Chemokine-Like Protein TAFA-1; Family With Sequence Similarity 19 (Chemokine (C-C motif)-Like), Member A1; Protein FAM19A1; Famil
I-309 蛋白/CC 趋化因子配体 1 蛋白
CCL1 Protein, Human 是一种细胞趋化因子，通过与细胞表面的 CCR8 趋化因子受体相互作用，吸引单核细胞、自然杀伤细胞、未成熟的 B 细胞核树突状细胞，介导炎症免疫反应、病毒感染以及肿瘤发生等。I-309/CCL1 Protein, Human 是一种由 E. coli表达的重组人CCL1(K24-K96)。
CTACK 蛋白/CC 趋化因子配体 27 蛋白
CTACK/CCL27 Protein, Human 是一种 CC 趋化因子，可以与趋化因子受体 CCR10 结合作用，吸引皮肤相关记忆 T 淋巴细胞，介导淋巴细胞归巢至皮肤部位，在皮肤炎症中起着关键作用。CTACK/CCL27 Protein, Human 一种由 E. coli 表达的重组人 CTACK/CCL27 (F25-G112) 蛋白。
Protein FAM19A4; Chemokine-like protein TAFA-4; TAFA4; family with sequence similarity 19 (chemokine (C-C motif)-like); member A4; FAM19A4; chemokine-like protein TAFA-4
RBM14; SIP; RNA-binding protein 14; Paraspeckle protein 2; PSP2; RNA-binding motif protein 14; RRM-containing coactivator activator/modulator; Synaptotagmin-interacting protein; SYT-interacting protein
RANTES 蛋白/CC 趋化因子配体 5 蛋白
RANTES/CCL5 Protein 是一种位于细胞膜外的分泌蛋白，也是 CC 趋化因子家族中的关键促炎趋化因子和免疫调节分子。RANTES/CCL5 Protein 通过其特异性 G 蛋白偶联受体 (GPCR) CCR1、CCR3 和 CCR5 发出信号，从而介导炎症免疫反应、病毒感染和肿瘤发生。RANTES/CCL5 Protein 可以在大鼠中促进内皮细胞迁移、扩散和新生血管形成。RANTES/CCL5 Protein 可用于肿瘤、自身免疫性疾病、动脉粥样硬化疾病的研究。RANTES/CCL5 Protein, Human 是一种由 E. coli 表达的重组人 CCL5 (S24-S91) 蛋白。
A disintegrin and metalloproteinase with thrombospondin motifs 5; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 5; A Disintigrin And Metalloproteinase with ThromboSpondin motif-5; ADAM metallopeptidase with thrombospondin type 1 motif 5; ADAM TS 11; ADAM TS 5; ADAM TS5; ADAMTS 11; ADAMTS 5; ADAMTS11; ADMP 2; ADMP2; Aggrecanase 2; aggrecanase-2; FLJ36738; Implantin; ThromboSpondin motif-5.
WB, ICC/IF, FC
Human, Mouse, Rat
ADAMTS5 Antibody is an unconjugated, approximately 102 kDa, rabbit-derived, anti-ADAMTS5 monoclonal antibody. ADAMTS5 Antibody can be used for: WB, IF-Cell, FC expriments in human, mouse, rat background without labeling.
RBMX; HNRPG; RBMXP1; RNA-binding motif protein; X chromosome; Glycoprotein p43; Heterogeneous nuclear ribonucleoprotein G; hnRNP G
WB, IHC-F, IHC-P, ICC/IF
Human
hnRNP G Antibody (YA3029) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3029), targeting hnRNP G, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). hnRNP G Antibody (YA3029) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
NUDT19 Antibody (YA1450) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1450), targeting NUDT19, with a predicted molecular weight of 42 kDa (observed band size: 42 kDa). NUDT19 Antibody (YA1450) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, rat background.
RBMY1A1; RBM1; RBM2; YRRM1; YRRM2; RNA-binding motif protein, Y chromosome, family 1 member A1 ; RNA-binding motif protein 1; RNA-binding motif protein 2; Y chromosome RNA recognition motif 1; hRBMY
WB, IHC-P
Human
RBMY1A1 Antibody (YA5985) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to RBMY1A1. It can be applicated for WB, IHC-P assays, in the background of human.
APPL1; APPL; DIP13A; KIAA1428; DCC-interacting protein 13-alpha; Dip13-alpha; Adapter protein containing PH domain; PTB domain and leucine zipper motif 1
WB, IHC-P
Human, Mouse, Rat
APPL Antibody (YA2135) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2135), targeting APPL, with a predicted molecular weight of 80 kDa (observed band size: 80 kDa). APPL Antibody (YA2135) can be used for WB, IHC-P experiment in human, mouse, rat background.
TARC/CCL17 Antibody (YA1211) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1211), targeting TARC/CCL17. TARC/CCL17 Antibody (YA1211) can be used for IHC-P experiment in human background.
TIF1γ Antibody (YA5201) is a mouse-derived and non-conjugated monoclonal antibody, targeting to TIF1γ. It can be applicated for WB assays, in the background of human.
TRIM5; RNF88; Tripartite motif-containing protein 5; RING finger protein 88
WB, IHC-P, ICC/IF, ELISA
Human
TRIM5α Antibody (YA5087) is a mouse-derived and non-conjugated monoclonal antibody, targeting to TRIM5α. It can be applicated for WB, IHC-P, ICC/IF, ELISA assays, in the background of human.
RBM43; C2orf38; RNA-binding protein 43 ; RNA-binding motif protein 43
WB
Human
RBM43 Antibody (YA5955) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to RBM43. It can be applicated for WB assays, in the background of human.
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
WB, IHC-F, IHC-P, ICC/IF, IP
Human
PML Protein Antibody (YA1678) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1678), targeting PML Protein, with a predicted molecular weight of 98 kDa (observed band size: 98/117 kDa). PML Protein Antibody (YA1678) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC motif Receptor 3; Chemokine CXC motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.
WB
Human, Mouse, Rat
CXCR3 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR3 polyclonal antibody. CXCR3 Antibody can be used for: WB expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit, guinea pig background without labeling.
CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC motif Receptor 3; Chemokine CXC motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.
WB, ICC/IF, IP
Human
CXCR3 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR3 monoclonal antibody. CXCR3 Antibody can be used for: WB expriments in human background without labeling.
PML; MYL; RNF71; TRIM19; Protein PML; Promyelocytic leukemia protein; RING finger protein 71; Tripartite motif-containing protein 19
WB, IHC-P
Human
Phospho-PML Protein (Ser518) Antibody (YA2632) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2632), targeting Phospho-PML Protein (Ser518), with a predicted molecular weight of 98 kDa (observed band size: 98/117 kDa). Phospho-PML Protein (Ser518) Antibody (YA2632) can be used for WB, IHC-P experiment in human background.
MCP-1/CCL2; C-C motif chemokine 2; CCL 2; CCL2; CCL2_HUMAN; Chemokine (C C motif) ligand 2; Chemokine C C motif ligand 2; Chemokine CC motif Ligand 2; GDCF 2; GDCF 2 HC11; GDCF-2; GDCF2; HC11; HSMCR30; HSMCR30; JE; MCAF; MCP 1; MCP-1; MGC9434; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; Monocyte secretory protein JE; SCYA2; Small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig je); Small inducible cytokine A2; Small inducible cytokine subfamily A (Cys Cys), member 2; Small inducible cytokine subfamily A Cys Cys member 2; Small-inducible cytokine A2; SMC CF; SMC-CF; SMCCF.
WB, ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Rat
MCP1 Antibody is an unconjugated, approximately 11 kDa, rabbit-derived, anti-MCP1 polyclonal antibody. MCP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog, pig, horse, rabbit background without labeling.
C-X-C motif chemokine 4; CXCL4; Iroplact; OncostatinA; PF4; Platelet factor 4; SCYB4; short form; Small inducible cytokine subfamily member 4
WB, IHC-P, IP
Human, Rat
PF4 Antibody (YA3156) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3156), targeting PF4, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). PF4 Antibody (YA3156) can be used for WB, IHC-P, IP experiment in human, rat background.
IP10 Antibody (YA2542) is a non-conjugated IgG antibody, targeting IP10, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). IP10 Antibody (YA2542) can be used for WB experiment in human background.
E3 SUMO protein ligase TRIM28; E3 SUMO-protein ligase TRIM28; FLJ29029; KAP 1; KAP-1; KRAB associated protein 1; KRAB interacting protein 1; KRAB-associated protein 1; KRAB-interacting protein 1; KRIP 1; KRIP-1; KRIP1; Nuclear corepressor KAP 1; Nuclear corepressor KAP-1; RING finger protein 96; RNF96; TF1B; TIF1 beta; TIF1-beta; TIF1B; TIF1B_HUMAN; Transcription intermediary factor 1 beta; Transcription intermediary factor 1-beta; TRIM28; Tripartite motif containing 28; tripartite motif containing protein 28; Tripartite motif-containing protein 28.
WB, ICC/IF, IHC-P, IP
Human
TIF1β Antibody (YA5197) is a mouse-derived and non-conjugated monoclonal antibody, targeting to TIF1β. It can be applicated for WB, ICC/IF, IHC-P, IP assays, in the background of human.
CD185 Antibody (YA4714) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD185. It can be applicated for FC, ELISA assays, in the background of human.
MARK2 Antibody (YA2104) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2104), targeting MARK2, with a predicted molecular weight of 88 kDa (observed band size: 78, 82 kDa). MARK2 Antibody (YA2104) can be used for WB, FC experiment in human, mouse, rat background.
NDUFB9 Antibody (YA1340) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1340), targeting NDUFB9, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). NDUFB9 Antibody (YA1340) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.
SDF1 Antibody (YA3188) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3188), targeting SDF1, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). SDF1 Antibody (YA3188) can be used for WB, ICC/IF experiment in human background.
CCL2; MCP1; SCYA2; C-C motif chemokine 2; HC11; Monocyte chemoattractant protein 1; Monocyte chemotactic and activating factor; MCAF; Monocyte chemotactic protein 1; MCP-1; Monocyte secretory protein JE; Small-inducible cytokine A2
WB, ELISA
Human
CCL2 Antibody (YA4962) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CCL2. It can be applicated for WB, ELISA assays, in the background of human.
TIF1γ Antibody (YA5169) is a mouse-derived and non-conjugated monoclonal antibody, targeting to TIF1γ. It can be applicated for WB, ICC/IF, IHC-P assays, in the background of human, mouse, rat, bovine, dog, pig.
TRIM25; EFP; RNF147; ZNF147; E3 ubiquitin/ISG15 ligase TRIM25; Estrogen-responsive finger protein; RING finger protein 147; Tripartite motif-containing protein 25; Ubiquitin/ISG15-conjugating enzyme TRIM25; Zinc finger protein 147
WB, ICC/IF, IP
Human, Rat
TRIM25 Antibody (YA2278) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2278), targeting TRIM25, with a predicted molecular weight of 71 kDa (observed band size: 71 kDa). TRIM25 Antibody (YA2278) can be used for WB, ICC/IF, IP experiment in human, rat background.
Transcription intermediary factor 1-beta; TIF1-beta; E3 SUMO-protein ligase TRIM28; KRAB-associated protein 1; KAP-1; KRAB-interacting protein 1; KRIP-1; Nuclear corepressor KAP-1; RING finger protein 96; Tripartite motif-containing protein 28
WB, IHC-P, ICC/IF, IP, ELISA
Human, Mouse, Rat,
KAP1 Antibody (YA6223) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to KAP1. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.
10 kDa interferon gamma induced protein; C7; Chemokine (C X C motif) ligand 10; Chemokine CXC motif ligand 10; Crg 2; CRG2; CXCL 10; CXCL10; Gamma IP10; gIP 10; GIP10; IFI 10; IFI10; INP 10; INP10; Interferon activated gene 10; Interferon gamma induced cell line; Interferon inducible cytokine IP 10; MOB1; SCYB 10; SCYB10; Small inducible cytokine B10; Small inducible cytokine B10 precursor; Small inducible cytokine subfamily B (Cys X Cys) member 10; Gamma-IP-10.
ELISA, IHC-P, IHC-F, FC, ICC/IF
Human, Mouse, Rat,
CXCL10/IP10 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL10/IP10 polyclonal antibody. CXCL10/IP10 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.
CCL19 Antibody (YA1670) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1670), targeting CCL19, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). CCL19 Antibody (YA1670) can be used for WB, FC experiment in human background.
CCL19 beta Antibody (YA2923) is a non-conjugated IgG antibody, targeting CCL19 beta, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). CCL19 beta Antibody (YA2923) can be used for WB experiment in human background.
C C chemokine receptor type 2 antibody;
C C CKR 2 antibody;
C-C chemokine receptor type 2 antibody;
C-C CKR-2 antibody;
CC chemokine receptor type 2 antibody;
CC CKR 2 antibody;
CC-CKR-2 antibody;
CCCKR2 antibody;
CCR 2 antibody;
CCR-2 antibody;
CCR1L antibody;
CCR2 antibody;
CCR2_HUMAN antibody;
CCR2A antibody;
CCR2B antibody;
CCR5L antibody;
CD192 antibody;
CD192 antigen antibody;
Chemokine C C motif receptor 2 antibody;
Chemokine CC motif Receptor 2 antibody;
CKR 2 antibody;
CKR2 antibody;
CKR2A antibody;
CKR2B antibody;
CMKBR2 antibody;
MCP 1 R antibody;
MCP-1-R antibody;
MCP1 RECEPTOR antibody;
MCP1R antibody;
Monocyte chemoattractant protein 1 receptor antibody;
Monocyte Chemotactic Protein 1 Receptor antibody;
Monocyte Chemotactic Protein 1 Receptor antibody
WB, IHC-P, IP, FC
Human
CCR2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to CCR2. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human.
AMCFII; C-X-C motif chemokine 5; Cxcl5; CXCL5_HUMAN; ENA-78(1-78); ENA-78(9-78); ENA78; Epithelial derived neutrophil activating peptide 78; Epithelial derived neutrophil activating protein 78; Epithelial-derived neutrophil-activating protein 78; GCP2; LIX; Neutrophil activating peptide ENA 78; Neutrophil-activating peptide ENA-78; SCYB5; Scyb6; Small inducible cytokine B5; Small inducible cytokine subfamily B member 5; Small-inducible cytokine B5.
WB, ICC/IF, IP
Human
CXCL5 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL5 monoclonal antibody. CXCL5 Antibody can be used for: WB,ICC/IF,IP expriments in human background without labeling.
C-TAK1 antibody;
Cdc25C associated protein kinase 1 antibody;
Cdc25C-associated protein kinase 1 antibody;
cTAK1 antibody;
ELKL motif kinase 2 antibody;
EMK-2 antibody;
Emk2 antibody;
ETK 1 antibody;
KIAA4230 antibody;
KP78 antibody;
MAP microtubule affinity regulating kinase 3 antibody;
MAP/microtubule affinity-regulating kinase 3 antibody;
Mark3 antibody;
MARK3_HUMAN antibody;
Par 1a antibody;
PAR1A antibody;
Protein kinase STK10 antibody;
Ser/Thr protein kinase PAR-1 antibody;
Serine threonine protein kinase p78 antibody;
Serine/threonine-protein kinase p78 antibody;
SerThr protein kinase PAR 1 antibody;
WB, ICC/IF, IP, FC
Mouse, Human
MARK3 Antibody (YA2150) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2150), targeting MARK3, with a predicted molecular weight of 84 kDa (observed band size: 84 kDa). MARK3 Antibody (YA2150) can be used for WB, ICC/IF, IP, FC experiment in mouse, human background.
CCR7_HUMAN; BLR 2; BLR2; C C chemokine receptor type 7; C C CKR 7; CC chemokine receptor 7; CC chemokine receptor type 7; CC CKR 7; CCCKR7; CCR 7; CD 197; CD197; CD197 antigen; CDW197; Chemokine C C motif receptor 7; Chemokine C C receptor 7; Chemokine receptor 7-like protein; EBI 1; EBI1; Ebi1h; EBV Induced G Protein Coupled Receptor 1; Epstein Barr virus induced G protein coupled receptor; Epstein Barr virus induced gene 1; EVI 1; EVI1; Lymphocyte Specific G Protein Coupled Peptide Receptor; MGC108519; MIP 3 beta receptor; MIP3 Beta Receptor.
WB, IHC-P, ICC/IF, ELISA
Human, Mouse, Rat
CCR7 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-CCR7 polyclonal antibody. CCR7 Antibody can be used for: WB, ELISA, IHC-P, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.
Ala-IL-8; 77; Ser-IL-8; 72; 3 10C; 310C; AMCF 1; AMCF1; b ENAP; Bbeta thromboglobulin like protein; Beta thromboglobulin like protein; C-X-C motif chemokine 8; CXC chemokine ligand 8; CXCL 8; CXCL8; Emoctakin; GCP 1; GCP-1; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; Granulocyte chemotactic protein 1; IL 8; IL-8; IL-8; 1-77; IL-8; 9-77; IL8; IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; IL8_HUMAN; Inteleukin 8; Interleukin8; K 60; K60; LECT; LUCT; Lymphocyte derived neutrophil activating factor; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-b; MDNCF-c; MONAP; Monocyte derived neutrophil activating peptide; Monocyte derived neutrophil activating protein; Monocyte derived neutrophil chemotactic factor; Monocyte-derived neutrophil chemotactic factor; Monocyte-derived neutrophil-activating peptide; NAF; NAP 1; NAP-1; NAP1; Neutrophil activating factor; Neutrophil activating peptide 1; Neutrophil activating protein 1; Neutrophil-activating factor; Neutrophil-activating protein 1; Protein 3 10C; Protein 3-10C; SCYB 8; SCYB8; Small inducible cytokine subfamily B member 8; T cell chemotactic factor; T-cell chemotactic factor; TSG 1; TSG1
WB, ELISA
Human
IL-8 Antibody (YA5190) is a mouse-derived and non-conjugated monoclonal antibody, targeting to IL-8. It can be applicated for WB, ELISA assays, in the background of human.
